Product Overview

Gefitinib (Iressa) is a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor primarily used for targeted therapy of non-small cell lung cancer and is an important active pharmaceutical ingredient (API) in anti-tumor drug development. This product is applicable across the entire drug development chain, including process optimization, pilot-scale amplification, and commercial production. It is widely used in innovative drug development, generic drug preparation, and customized synthesis projects, meeting the stringent requirements of the pharmaceutical industry for high purity, stability, and compliance.

Applications

• Targeted Oncology Drug Development
• Synthesis of Anticancer Drug Intermediates
• Raw Material Supply for Generic Drug Formulations
• Development of Innovative Drug Process Routes
• Customized Mass Production Support

Quality & Supply Capability

English Name: Iressa Properties: Gefitinib is a white to off-white crystalline powder with good thermal stability. Its molecular structure contains a quinazoline ring and phenyl substituents, exhibiting potent EGFR inhibitory activity and meeting pharmaceutical-grade API standards. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide sample supply, small-scale preparation, pilot-scale amplification, and customized batch production services. We offer flexible supply solutions based on customer requirements for purity, impurity control, packaging specifications, delivery time, and quality documentation. We also provide technical support from laboratory R&D to scale-up production, helping customers advance process development, route optimization, and project transformation, ensuring high-quality delivery and compliance at every stage.

Why Choose Bioncan

Focused on the field of anti-tumor active pharmaceutical ingredients (APIs), possessing extensive product experience and technological expertise. Full-scale supply capabilities, covering all stages from laboratory to commercial production. Provides complete quality control documentation support, including COA, MSDS, HPLC, NMR, etc. Supports customized needs, enabling formulation adjustments and process optimization based on specific customer requirements. Supports scale-up technology to help customers achieve a seamless transition from R&D to mass production.

Online Consulting

For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 184475-35-2, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.